Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3476)
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
3,136
Price
$18.00
Total Value
$56.45K
Shares Held After
1,574,270
% of Holdings
0.2%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance & Operations
Shares
264
Price
$2.34
Total Value
$618.02
Shares Held After
506,997
% of Holdings
0.1%
IONIS PHARMACEUTICALS INC (IONS)
LOSCALZO JOSEPH — Director
Shares
17,781
Price
$75.58
Total Value
$1.34M
Shares Held After
36,330
% of Holdings
32.9%
IONIS PHARMACEUTICALS INC (IONS)
LOSCALZO JOSEPH — Director
Shares
59,508
Price
$74.90
Total Value
$4.46M
Shares Held After
54,111
% of Holdings
52.4%
Celcuity Inc. (CELC)
Dalvey David — Director
Shares
25,000
Price
$140.68
Total Value
$3.52M
Shares Held After
65,000
% of Holdings
27.8%
Tectonic Therapeutic, Inc. (TECX)
Ruddy Marcella K. — Chief Medical Officer
Shares
1,065
Price
$30.00
Total Value
$31.95K
Shares Held After
67,682
% of Holdings
1.5%
INSMED Inc (INSM)
Lewis William — Director
Shares
381
Price
$139.60
Total Value
$53.19K
Shares Held After
301,185
% of Holdings
0.1%
INSMED Inc (INSM)
Lewis William — Director
Shares
1,247
Price
$139.09
Total Value
$173.45K
Shares Held After
301,566
% of Holdings
0.4%
INSMED Inc (INSM)
Lewis William — Director
Shares
2,721
Price
$137.86
Total Value
$375.12K
Shares Held After
302,813
% of Holdings
0.9%
INSMED Inc (INSM)
Lewis William — Director
Shares
5,318
Price
$137.01
Total Value
$728.62K
Shares Held After
305,534
% of Holdings
1.7%
INSMED Inc (INSM)
Lewis William — Director
Shares
599
Price
$135.18
Total Value
$80.97K
Shares Held After
310,852
% of Holdings
0.2%
INSMED Inc (INSM)
Lewis William — Director
Shares
433
Price
$134.18
Total Value
$58.10K
Shares Held After
311,451
% of Holdings
0.1%
Celcuity Inc. (CELC)
Buller Richard E — Director
Shares
365
Price
$143.24
Total Value
$52.28K
Shares Held After
6,760
% of Holdings
5.1%
Celcuity Inc. (CELC)
Buller Richard E — Director
Shares
2,825
Price
$142.04
Total Value
$401.25K
Shares Held After
7,125
% of Holdings
28.4%
Celcuity Inc. (CELC)
Buller Richard E — Director
Shares
2,301
Price
$141.03
Total Value
$324.50K
Shares Held After
9,950
% of Holdings
18.8%
Celcuity Inc. (CELC)
Buller Richard E — Director
Shares
1,670
Price
$139.58
Total Value
$233.10K
Shares Held After
12,251
% of Holdings
12.0%
Celcuity Inc. (CELC)
Buller Richard E — Director
Shares
550
Price
$139.00
Total Value
$76.45K
Shares Held After
13,921
% of Holdings
3.8%
Celcuity Inc. (CELC)
Buller Richard E — Director
Shares
1,289
Price
$137.00
Total Value
$176.59K
Shares Held After
14,471
% of Holdings
8.2%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
2,111
Price
$102.88
Total Value
$217.18K
Shares Held After
324,879
% of Holdings
0.6%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
17,353
Price
$102.10
Total Value
$1.77M
Shares Held After
326,990
% of Holdings
5.0%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
7,429
Price
$101.48
Total Value
$753.89K
Shares Held After
344,343
% of Holdings
2.1%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
1,408
Price
$99.77
Total Value
$140.48K
Shares Held After
351,772
% of Holdings
0.4%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
1,699
Price
$98.54
Total Value
$167.42K
Shares Held After
353,180
% of Holdings
0.5%
Verastem, Inc. (VSTM)
Paterson Dan — Director
Shares
806
Price
$5.82
Total Value
$4.69K
Shares Held After
612,113
% of Holdings
0.1%
Axsome Therapeutics, Inc. (AXSM)
Jacobson Mark L. — Chief Operating Officer
Shares
4,517
Price
$227.94
Total Value
$1.03M
Shares Held After
0
% of Holdings
100.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
72,884
Price
$6.80
Total Value
$495.61K
Shares Held After
198,890
% of Holdings
26.8%
ACADIA PHARMACEUTICALS INC (ACAD)
Kihara James — PRINCIPAL ACCOUNTING OFFICER
Shares
1,332
Price
$21.79
Total Value
$29.02K
Shares Held After
29,129
% of Holdings
4.4%
ACADIA PHARMACEUTICALS INC (ACAD)
Schneyer Mark C. — EVP, CHIEF FINANCIAL OFFICER
Shares
3,506
Price
$21.79
Total Value
$76.40K
Shares Held After
66,145
% of Holdings
5.0%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bhatia Sangeeta N. — Director
Shares
318
Price
$423.73
Total Value
$134.75K
Shares Held After
4,924
% of Holdings
6.1%
Surrozen, Inc./DE (SRZN)
Parker Craig C — Director
Shares
4,524
Price
$33.33
Total Value
$150.80K
Shares Held After
16,553
% of Holdings
21.5%
Surrozen, Inc./DE (SRZN)
Williams Charles O — Chief Operating Officer
Shares
2,036
Price
$33.33
Total Value
$67.87K
Shares Held After
16,571
% of Holdings
10.9%
Surrozen, Inc./DE (SRZN)
Li Yang — Exec. Vice President, Research
Shares
1,584
Price
$33.33
Total Value
$52.80K
Shares Held After
17,216
% of Holdings
8.4%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
172
Price
$157.49
Total Value
$27.09K
Shares Held After
2,666
% of Holdings
6.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
235
Price
$156.57
Total Value
$36.79K
Shares Held After
2,838
% of Holdings
7.6%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
325
Price
$155.21
Total Value
$50.44K
Shares Held After
3,073
% of Holdings
9.6%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
236
Price
$154.24
Total Value
$36.40K
Shares Held After
3,398
% of Holdings
6.5%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
32
Price
$153.50
Total Value
$4.91K
Shares Held After
3,634
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
400
Price
$582.29
Total Value
$232.92K
Shares Held After
18,876
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
520
Price
$581.28
Total Value
$302.27K
Shares Held After
19,276
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
440
Price
$580.26
Total Value
$255.31K
Shares Held After
19,796
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,160
Price
$579.13
Total Value
$671.79K
Shares Held After
20,236
% of Holdings
5.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
719
Price
$577.54
Total Value
$415.25K
Shares Held After
21,396
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
3,005
Price
$576.66
Total Value
$1.73M
Shares Held After
22,115
% of Holdings
12.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,436
Price
$575.75
Total Value
$1.40M
Shares Held After
25,120
% of Holdings
8.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
487
Price
$574.84
Total Value
$279.95K
Shares Held After
27,556
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
153
Price
$573.82
Total Value
$87.79K
Shares Held After
28,043
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
480
Price
$572.40
Total Value
$274.75K
Shares Held After
28,196
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$571.00
Total Value
$22.84K
Shares Held After
28,676
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
80
Price
$570.06
Total Value
$45.60K
Shares Held After
28,716
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
80
Price
$568.60
Total Value
$45.49K
Shares Held After
28,796
% of Holdings
0.3%
Showing 1501–1550 of 3476 transactions (page 31 of 70)